Fig. 6From: Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drugRMSF graph based on ligand-free protein and ligand bounded protein complex of C-MET proteinBack to article page